Sort
23,748 grants matching “melanoma”
Mechanism of myeloid cell defect in cancer
$311,376Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2016 · CA
Molecular Determinants of Androgen Receptor Function
$311,323Elizabeth M. Wilson · Univ Of North Carolina Chapel Hill · U54 · FY2008 · HD
Context-specific Functions of CDK8
$311,275Jun-Yuan Ji · Tulane University Of Louisiana · R01 · FY2021 · GM
Mechanism of keratinocyte RXRalpha mediated melanoma skin cancer development
$311,272Arup K. Indra · Oregon State University · R01 · FY2012 · ES
Small molecule targeting of MIF as a novel melanoma therapeutic
$311,250Robert A. Mitchell · University Of Louisville · R01 · FY2018 · CA
Small molecule targeting of MIF as a novel melanoma therapeutic
$311,250Robert A. Mitchell · University Of Louisville · R01 · FY2016 · CA
TLR2 Engagement on Tumor-Specific T Cells: Mechanisms of Costimulation
$311,250Eduardo Davila · University Of Maryland Baltimore · R01 · FY2010 · CA
Small molecule targeting of MIF as a novel melanoma therapeutic
$311,250Robert A. Mitchell · University Of Louisville · R01 · FY2015 · CA
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas
$311,250Brian R Gastman · University Of Maryland Baltimore · R01 · FY2009 · CA
Small molecule targeting of MIF as a novel melanoma therapeutic
$311,250Robert A. Mitchell · University Of Louisville · R01 · FY2017 · CA
Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine:
$311,250Edward A Sausville · University Of Maryland Baltimore · R21 · FY2009 · CA
Skin Cancer and Arsenic Exposure
$311,250Leslie K Dennis · University Of Iowa · R01 · FY2009 · CA
Small molecule targeting of MIF as a novel melanoma therapeutic
$311,250Robert A. Mitchell · University Of Louisville · R01 · FY2014 · CA
Importance of Gender in the Chemoprevention of UV induced Skin Cancer
$311,250Tatiana M Oberyszyn · Ohio State University · R01 · FY2010 · CA
Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine:
$311,250Edward A Sausville · University Of Maryland Baltimore · R21 · FY2008 · CA
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas
$311,250Brian R Gastman · University Of Maryland Baltimore · R01 · FY2008 · CA
Skin Cancer and Arsenic Exposure
$311,250Leslie K Dennis · University Of Iowa · R01 · FY2008 · CA
Importance of Gender in the Chemoprevention of UV induced Skin Cancer
$311,250Tatiana M Oberyszyn · Ohio State University · R01 · FY2009 · CA
Mechanism of Resistance to Arginine Deiminase Therapy in Advance Melanoma
$311,230Macus T Kuo · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
$311,229Jonathan P Schneck · Johns Hopkins University · P41 · FY2021 · EB
Core C: Cell Biology Core
$311,228Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA
Durable CD4+ T-cell Tumor Immunity Following Gene-modified HPSC
$311,223Christopher E. Touloukian · Indiana University Indianapolis · R01 · FY2010 · CA
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
$311,178Harriet M Kluger · Yale University · P50 · FY2022 · CA
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
$311,165Raphael Kopan · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · CA
In-situ activation of anti-tumor effectors
$311,150Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R56 · FY2007 · CA